Inflammatory markers neopterin and alanine aminotransferase in HCV patients treated with HCV NS3•4A protease inhibitor telaprevir (VX-950) and/or peginterferon alfa-2a

Author： Gelderblom Huub   Zeuzem Stefan   Weegink Christine   Forestier Nicole   Mcnair Lindsay   Purdy Susan   Dijkgraaf Marcel   Jansen Peter   Reesink Henk  

Publisher： Informa Healthcare

ISSN： 0036-5521

Source： Scandinavian Journal of Gastroenterology, Vol.43, Iss.9, 2008-01, pp. : 1122-1127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Peginterferon alfa-2a relapse rates depend on weight-based ribavirin dosage in HCV-infected patients with genotype 1: Results of a retrospective evaluation

By Zopf Steffen   Herold Christoph   Hahn Eckhart   Ganslmayer Marion  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 4, 2009-04 ,pp. : 486-490

Informa Healthcare

Access to resources Recommend Favorite

Prediction of sustained virological response in chronic hepatitis C patients treated with peginterferon alfa-2a (40KD) and ribavirin

By Foster Graham   Fried Michael   Hadziyannis Stephanos   Messinger Diethelm   Freivogel Klaus   Weiland Ola  

Scandinavian Journal of Gastroenterology, Vol. 42, Iss. 2, 2007-01 ,pp. : 247-255

Informa Healthcare

Access to resources Recommend Favorite

Predictive Factors for Response to Peginterferon-Alpha and Ribavirin Treatment of Chronic HCV Infection in Patients Aged 65 Years and More

By Giannini Edoardo   Basso Monica   Savarino Vincenzo   Picciotto Antonino  

Digestive Diseases and Sciences, Vol. 55, Iss. 11, 2010-11 ,pp. : 3193-3199

Springer Publishing Company

Access to resources Recommend Favorite

The Effect of Unsuccessful Treatment with Peginterferon and Ribavirin on the Liver Fibrosis Course of HIV/HCV-Coinfected Patients

By  

Current HIV Research, Vol. 10, Iss. 8, 2012-12 ,pp. : 679-687

Bentham Science Publishers

Access to resources Recommend Favorite

Peginterferon Alfa-2a Is Superior to Peginterferon Alfa-2b in the Treatment of Naïve Patients with Hepatitis C Virus Infection: Meta-Analysis of Randomized Controlled Trials

By Singal Ashwani  

Digestive Diseases and Sciences, Vol. 56, Iss. 8, 2011-08 ,pp. : 2221-2226

Springer Publishing Company

Access to resources Recommend Favorite